{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T14:57:40Z","timestamp":1794236260188,"version":"4.9.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T00:00:00Z","timestamp":1739232000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T00:00:00Z","timestamp":1739232000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"DOI":"10.1186\/s12882-025-03992-w","type":"journal-article","created":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T14:52:34Z","timestamp":1739285554000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Association of aberrant mineral metabolic markers with fracture risk in chronic kidney disease: a comprehensive meta-analysis"],"prefix":"10.1186","volume":"26","author":[{"given":"Yao","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen Xing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen Sheng","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi Bin","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui Min","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiu Hong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,11]]},"reference":[{"issue":"22","key":"3992_CR1","doi-asserted-by":"publisher","first-page":"6984","DOI":"10.3390\/jcm12226984","volume":"12","author":"S Swamy","year":"2023","unstructured":"Swamy S, Noor SM, Mathew RO. Cardiovascular disease in diabetes and chronic kidney disease. J Clin Med. 2023;12(22):6984. https:\/\/doi.org\/10.3390\/jcm12226984.","journal-title":"J Clin Med"},{"issue":"1","key":"3992_CR2","doi-asserted-by":"publisher","first-page":"167","DOI":"10.3390\/nu15010167","volume":"15","author":"E Bellorin-Font","year":"2022","unstructured":"Bellorin-Font E, Rojas E, Martin KJ. Bone disease in chronic kidney disease and kidney transplant. Nutrients. 2022;15(1):167. https:\/\/doi.org\/10.3390\/nu15010167.","journal-title":"Nutrients"},{"issue":"Suppl 1","key":"3992_CR3","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1007\/s10157-016-1368-3","volume":"21","author":"JJ Kazama","year":"2017","unstructured":"Kazama JJ. Chronic kidney disease and fragility fracture. Clin Exp Nephrol. 2017;21(Suppl 1):46\u201352. https:\/\/doi.org\/10.1007\/s10157-016-1368-3.","journal-title":"Clin Exp Nephrol"},{"issue":"7","key":"3992_CR4","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1038\/sj.ki.5001754","volume":"70","author":"M Jadoul","year":"2006","unstructured":"Jadoul M, Albert JM, Akiba T, Akizawa T, Arab L, Bragg-Gresham JL, et al. Incidence and risk factors for hip or other bone fractures among hemodialysis patients in the dialysis outcomes and practice patterns study. Kidney Int. 2006;70(7):1358\u201366. https:\/\/doi.org\/10.1038\/sj.ki.5001754.","journal-title":"Kidney Int"},{"issue":"4","key":"3992_CR5","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1055\/s-0043-1770353","volume":"27","author":"MH Lafage-Proust","year":"2023","unstructured":"Lafage-Proust MH. Bone and chronic kidney disease. Semin Musculoskelet Radiol. 2023;27(4):463\u201370. https:\/\/doi.org\/10.1055\/s-0043-1770353.","journal-title":"Semin Musculoskelet Radiol"},{"issue":"3","key":"3992_CR6","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1093\/ckj\/sfac230","volume":"16","author":"M Haarhaus","year":"2022","unstructured":"Haarhaus M, Aaltonen L, Cejka D, Cozzolino M, de Jong RT, D\u2019Haese P, et al. Management of fracture risk in CKD-traditional and novel approaches. Clin Kidney J. 2022;16(3):456\u201372. https:\/\/doi.org\/10.1093\/ckj\/sfac230.","journal-title":"Clin Kidney J"},{"issue":"4","key":"3992_CR7","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1053\/j.ajkd.2020.12.024","volume":"78","author":"M Pazianas","year":"2021","unstructured":"Pazianas M, Miller PD. Osteoporosis and Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD): back to basics. Am J Kidney Dis. 2021;78(4):582\u20139. https:\/\/doi.org\/10.1053\/j.ajkd.2020.12.024.","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"3992_CR8","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1093\/ndt\/gfz196","volume":"36","author":"M Fusaro","year":"2021","unstructured":"Fusaro M, Holden R, Lok C, Iervasi G, Plebani M, Aghi A, et al. Phosphate and bone fracture risk in chronic kidney disease patients. Nephrol Dial Transplant. 2021;36(3):405\u201312. https:\/\/doi.org\/10.1093\/ndt\/gfz196.","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"3992_CR9","doi-asserted-by":"publisher","first-page":"2200","DOI":"10.1111\/j.1523-1755.2000.00394.x","volume":"58","author":"CO Stehman-Breen","year":"2000","unstructured":"Stehman-Breen CO, Sherrard DJ, Alem AM, Gillen DL, Heckbert SR, Wong CS, et al. Risk factors for hip fracture among patients with end-stage renal disease. Kidney Int. 2000;58(5):2200\u20135. https:\/\/doi.org\/10.1111\/j.1523-1755.2000.00394.x.","journal-title":"Kidney Int"},{"issue":"1","key":"3992_CR10","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1053\/j.ajkd.2005.09.024","volume":"47","author":"MD Danese","year":"2006","unstructured":"Danese MD, Kim J, Doan QV, Dylan M, Griffiths R, Chertow GM. PTH and the risks for hip, vertebral, and pelvic fractures among patients on dialysis. Am J Kidney Dis. 2006;47(1):149\u201356. https:\/\/doi.org\/10.1053\/j.ajkd.2005.09.024.","journal-title":"Am J Kidney Dis"},{"issue":"8","key":"3992_CR11","doi-asserted-by":"publisher","first-page":"3323","DOI":"10.1210\/jc.2013-1152","volume":"98","author":"A Jovanovich","year":"2013","unstructured":"Jovanovich A, B\u00f9zkov\u00e1 P, Chonchol M, Robbins J, Fink HA, de Boer IH, et al. Fibroblast growth factor 23, bone mineral density, and risk of hip fracture among older adults: the cardiovascular health study. J Clin Endocrinol Metab. 2013;98(8):3323\u201331. https:\/\/doi.org\/10.1210\/jc.2013-1152.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"3992_CR12","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/s0272-6386(99)70302-1","volume":"33","author":"K Atsumi","year":"1999","unstructured":"Atsumi K, Kushida K, Yamazaki K, Shimizu S, Ohmura A, Inoue T. Risk factors for vertebral fractures in renal osteodystrophy. Am J Kidney Dis. 1999;33(2):287\u201393. https:\/\/doi.org\/10.1016\/s0272-6386(99)70302-1.","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"3992_CR13","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1053\/ajkd.2000.19812","volume":"36","author":"M Coco","year":"2000","unstructured":"Coco M, Rush H. Increased incidence of hip fractures in dialysis patients with low serum parathyroid hormone. Am J Kidney Dis. 2000;36(6):1115\u201321. https:\/\/doi.org\/10.1053\/ajkd.2000.19812.","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"3992_CR14","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1111\/j.1523-1755.2005.00596.x","volume":"68","author":"J Cunningham","year":"2005","unstructured":"Cunningham J, Danese M, Olson K, Klassen P, Chertow GM. Effects of the calcimimetic cinacalcet HCl on cardiovascular disease, fracture, and health-related quality of life in secondary hyperparathyroidism. Kidney Int. 2005;68(4):1793\u2013800. https:\/\/doi.org\/10.1111\/j.1523-1755.2005.00596.x.","journal-title":"Kidney Int"},{"key":"3992_CR15","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/1471-2369-13-122","volume":"13","author":"E Kanda","year":"2012","unstructured":"Kanda E, Yoshida M, Sasaki S. Applicability of fibroblast growth factor 23 for evaluation of risk of vertebral fracture and chronic kidney disease-mineral bone disease in elderly chronic kidney disease patients. BMC Nephrol. 2012;13:122. https:\/\/doi.org\/10.1186\/1471-2369-13-122.","journal-title":"BMC Nephrol"},{"issue":"11","key":"3992_CR16","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1002\/jbmr.1985","volume":"28","author":"NE Lane","year":"2013","unstructured":"Lane NE, Parimi N, Corr M, Yao W, Cauley JA, Nielson CM, et al. Association of serum fibroblast growth factor 23 (FGF23) and incident fractures in older men: the Osteoporotic Fractures in Men (MrOS) study. J Bone Miner Res. 2013;28(11):2325\u201332. https:\/\/doi.org\/10.1002\/jbmr.1985.","journal-title":"J Bone Miner Res"},{"issue":"5","key":"3992_CR17","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1007\/s00198-014-2632-6","volume":"25","author":"YJ Chen","year":"2014","unstructured":"Chen YJ, Kung PT, Wang YH, Huang CC, Hsu SC, Tsai WC, et al. Greater risk of hip fracture in hemodialysis than in peritoneal dialysis. Osteoporos Int. 2014;25(5):1513\u20138. https:\/\/doi.org\/10.1007\/s00198-014-2632-6. Epub 2014 Feb 21.","journal-title":"Osteoporos Int"},{"issue":"4","key":"3992_CR18","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1002\/jbmr.2750","volume":"31","author":"T Isakova","year":"2016","unstructured":"Isakova T, Cai X, Lee J, Katz R, Cauley JA, Fried LF, et al. Associations of FGF23 with change in bone mineral density and fracture risk in older individuals. J Bone Miner Res. 2016;31(4):742\u20138. https:\/\/doi.org\/10.1002\/jbmr.2750. Epub 2015 Dec 23.","journal-title":"J Bone Miner Res"},{"issue":"6","key":"3992_CR19","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1681\/ASN.2014040414","volume":"26","author":"SM Moe","year":"2015","unstructured":"Moe SM, Abdalla S, Chertow GM, Parfrey PS, Block GA, Correa-Rotter R, et al. Effects of cinacalcet on fracture events in patients receiving hemodialysis: the EVOLVE trial. J Am Soc Nephrol. 2015;26(6):1466\u201375. https:\/\/doi.org\/10.1681\/ASN.2014040414.","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"3992_CR20","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.2215\/CJN.09280915","volume":"11","author":"S Fishbane","year":"2016","unstructured":"Fishbane S, Hazzan AD, Jhaveri KD, Ma L, Lacson E Jr. Bone parameters and risk of hip and femur fractures in patients on hemodialysis. Clin J Am Soc Nephrol. 2016;11(6):1063\u201372. https:\/\/doi.org\/10.2215\/CJN.09280915.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"7","key":"3992_CR21","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1093\/ndt\/gfw222","volume":"32","author":"V Dey","year":"2017","unstructured":"Dey V, Farrah TE, Traynor JP, Spalding EM, Robertson SE, Geddes CC. Symptomatic fracture risk in the renal replacement therapy population. Nephrol Dial Transplant. 2017;32(7):1211\u20136. https:\/\/doi.org\/10.1093\/ndt\/gfw222.","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"3992_CR22","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1038\/s41598-018-20552-5","volume":"8","author":"M Evans","year":"2018","unstructured":"Evans M, Methven S, Gasparini A, Barany P, Birnie K, MacNeill S, et al. Cinacalcet use and the risk of cardiovascular events, fractures and mortality in chronic kidney disease patients with secondary hyperparathyroidism. Sci Rep. 2018;8(1):2103. https:\/\/doi.org\/10.1038\/s41598-018-20552-5.","journal-title":"Sci Rep"},{"issue":"4","key":"3992_CR23","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1159\/000492603","volume":"140","author":"A Hutchison","year":"2018","unstructured":"Hutchison A, Whelton A, Thadhani R, Achenbach H, Vergani A, Wu J, et al. Long-term mortality and bone safety in patients with end-stage renal disease receiving lanthanum carbonate. Nephron. 2018;140(4):265\u201374. https:\/\/doi.org\/10.1159\/000492603.","journal-title":"Nephron"},{"issue":"4","key":"3992_CR24","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1007\/s00198-019-04902-1","volume":"30","author":"LC Desbiens","year":"2019","unstructured":"Desbiens LC, Goupil R, Sidib\u00e9 A, Madore F, Mac-Way F. Fracture status in middle-aged individuals with early CKD: cross-sectional analysis of the CARTaGENE survey. Osteoporos Int. 2019;30(4):787\u201395. https:\/\/doi.org\/10.1007\/s00198-019-04902-1.","journal-title":"Osteoporos Int"},{"issue":"10","key":"3992_CR25","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1007\/s00198-019-05033-3","volume":"30","author":"S Geng","year":"2019","unstructured":"Geng S, Kuang Z, Peissig PL, Page D, Maursetter L, Hansen KE. Parathyroid hormone independently predicts fracture, vascular events, and death in patients with stage 3 and 4 chronic kidney disease. Osteoporos Int. 2019;30(10):2019\u201325. https:\/\/doi.org\/10.1007\/s00198-019-05033-3.","journal-title":"Osteoporos Int"},{"issue":"2","key":"3992_CR26","doi-asserted-by":"publisher","first-page":"220","DOI":"10.23876\/j.krcp.18.0099","volume":"38","author":"YE Kwon","year":"2019","unstructured":"Kwon YE, Choi HY, Kim S, Ryu DR, Oh HJ, ESRD Registry Committee of the Korean Society of Nephrology. Fracture risk in chronic kidney disease: a Korean population-based cohort study. Kidney Res Clin Pract. 2019;38(2):220\u20138. https:\/\/doi.org\/10.23876\/j.krcp.18.0099.","journal-title":"Kidney Res Clin Pract."},{"issue":"6","key":"3992_CR27","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1111\/1744-9987.12807","volume":"23","author":"M Wakasugi","year":"2019","unstructured":"Wakasugi M, Kazama JJ, Kikuchi K, Yasuda K, Wada A, Hamano T, et al. Hemodialysis product and hip fracture in hemodialysis patients: a nationwide cohort study in Japan. Ther Apher Dial. 2019;23(6):507\u201317. https:\/\/doi.org\/10.1111\/1744-9987.12807.","journal-title":"Ther Apher Dial"},{"issue":"3","key":"3992_CR28","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1007\/s00198-019-05187-0","volume":"31","author":"TT Jansz","year":"2020","unstructured":"Jansz TT, Goto NA, van Ballegooijen AJ, Willems HC, Verhaar MC, van Jaarsveld BC. The prevalence and incidence of vertebral fractures in end-stage renal disease and the role of parathyroid hormone. Osteoporos Int. 2020;31(3):515\u201324. https:\/\/doi.org\/10.1007\/s00198-019-05187-0.","journal-title":"Osteoporos Int"},{"issue":"2","key":"3992_CR29","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s00774-019-01041-9","volume":"38","author":"PJ Matias","year":"2020","unstructured":"Matias PJ, Laranjinha I, Azevedo A, Raimundo A, Navarro D, Jorge C, et al. Bone fracture risk factors in prevalent hemodialysis patients. J Bone Miner Metab. 2020;38(2):205\u201312. https:\/\/doi.org\/10.1007\/s00774-019-01041-9.","journal-title":"J Bone Miner Metab"},{"issue":"1","key":"3992_CR30","doi-asserted-by":"publisher","first-page":"107476","DOI":"10.1016\/j.jdiacomp.2019.107476","volume":"34","author":"AL Ribeiro","year":"2020","unstructured":"Ribeiro AL, Mendes F, Carias E, Rato F, Santos N, Neves PL, et al. FGF23-klotho axis as predictive factors of fractures in type 2 diabetics with early chronic kidney disease. J Diabetes Complications. 2020;34(1):107476. https:\/\/doi.org\/10.1016\/j.jdiacomp.2019.107476.","journal-title":"J Diabetes Complications"},{"issue":"19","key":"3992_CR31","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1001\/jama.2021.4807","volume":"325","author":"H Ogata","year":"2021","unstructured":"Ogata H, Fukagawa M, Hirakata H, Kagimura T, Fukushima M, Akizawa T, et al. Effect of treating hyperphosphatemia with lanthanum carbonate vs calcium carbonate on cardiovascular events in patients with chronic kidney disease undergoing hemodialysis: the LANDMARK randomized clinical trial. JAMA. 2021;325(19):1946\u201354. https:\/\/doi.org\/10.1001\/jama.2021.4807.","journal-title":"JAMA"},{"issue":"3","key":"3992_CR32","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1002\/jbmr.4214","volume":"36","author":"M Fusaro","year":"2021","unstructured":"Fusaro M, Cozzolino M, Plebani M, Iervasi G, Ketteler M, Gallieni M, et al. Sevelamer use, vitamin k levels, vascular calcifications, and vertebral fractures in hemodialysis patients: results from the VIKI study. J Bone Miner Res. 2021;36(3):500\u20139. https:\/\/doi.org\/10.1002\/jbmr.4214.","journal-title":"J Bone Miner Res"},{"issue":"12","key":"3992_CR33","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.1002\/jbmr.4440","volume":"36","author":"M Fusaro","year":"2021","unstructured":"Fusaro M, Cianciolo G, Tripepi G, Plebani M, Aghi A, Politi C, et al. Oral calcitriol use, vertebral fractures, and vitamin K in hemodialysis patients: a cross-sectional study. J Bone Miner Res. 2021;36(12):2361\u201370. https:\/\/doi.org\/10.1002\/jbmr.4440.","journal-title":"J Bone Miner Res"},{"issue":"1","key":"3992_CR34","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12882-020-02224-7","volume":"22","author":"L Xie","year":"2021","unstructured":"Xie L, Hu X, Li W, Ouyang Z. A retrospective study of end-stage kidney disease patients on maintenance hemodialysis with renal osteodystrophy-associated fragility fractures. BMC Nephrol. 2021;22(1):23. https:\/\/doi.org\/10.1186\/s12882-020-02224-7.","journal-title":"BMC Nephrol"},{"issue":"8","key":"3992_CR35","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.3390\/nu13082847","volume":"13","author":"M Yoshida","year":"2021","unstructured":"Yoshida M, Nakashima A, Doi S, Maeda K, Ishiuchi N, Naito T, et al. Lower Geriatric Nutritional Risk Index (GNRI) is associated with higher risk of fractures in patients undergoing hemodialysis. Nutrients. 2021;13(8):2847. https:\/\/doi.org\/10.3390\/nu13082847.","journal-title":"Nutrients"},{"issue":"6","key":"3992_CR36","doi-asserted-by":"publisher","first-page":"e2502","DOI":"10.1210\/clinem\/dgac071","volume":"107","author":"LC Desbiens","year":"2022","unstructured":"Desbiens LC, Sidib\u00e9 A, Ung RV, Mac-Way F. FGF23-klotho axis and fractures in patients without and with early CKD: a case-cohort analysis of CARTaGENE. J Clin Endocrinol Metab. 2022;107(6):e2502\u201312. https:\/\/doi.org\/10.1210\/clinem\/dgac071.","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"3992_CR37","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1002\/jbmr.4621","volume":"37","author":"M Murashima","year":"2022","unstructured":"Murashima M, Hamano T, Nishiyama T, Tsuruya K, Ogata S, Kanda E, et al. Performance status modifies the association between vitamin D receptor activator and mortality or fracture: a prospective cohort study on the Japanese Society for Dialysis Therapy (JSDT) renal data registry. J Bone Miner Res. 2022;37(8):1489\u201399. https:\/\/doi.org\/10.1002\/jbmr.4621.","journal-title":"J Bone Miner Res"},{"key":"3992_CR38","doi-asserted-by":"publisher","first-page":"9998891","DOI":"10.1155\/2022\/9998891","volume":"2022","author":"TK Young","year":"2022","unstructured":"Young TK, Toussaint ND, Di Tanna GL, Arnott C, Hockham C, Kang A, et al. Risk factors for fracture in patients with coexisting chronic kidney disease and type 2 diabetes: an observational analysis from the CREDENCE trial. J Diabetes Res. 2022;2022:9998891. https:\/\/doi.org\/10.1155\/2022\/9998891.","journal-title":"J Diabetes Res"},{"key":"3992_CR39","doi-asserted-by":"publisher","unstructured":"Barrera-Baena P, Rodr\u00edguez-Garc\u00eda M, Rodr\u00edguez-Rubio E, Gonz\u00e1lez-Llorente L, Ortiz A, Zoccali C, et al. Serum phosphate is associated with increased risk of bone fragility fractures in hemodialysis patients. Nephrol Dial Transplant. 2023:gfad190. https:\/\/doi.org\/10.1093\/ndt\/gfad190.","DOI":"10.1093\/ndt\/gfad190"},{"issue":"6","key":"3992_CR40","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1093\/ndt\/gfy287","volume":"34","author":"N Carrillo-L\u00f3pez","year":"2019","unstructured":"Carrillo-L\u00f3pez N, Panizo S, Alonso-Montes C, Mart\u00ednez-Arias L, Avello N, Sosa P, et al. High-serum phosphate and parathyroid hormone distinctly regulate bone loss and vascular calcification in experimental chronic kidney disease. Nephrol Dial Transplant. 2019;34(6):934\u201341. https:\/\/doi.org\/10.1093\/ndt\/gfy287.","journal-title":"Nephrol Dial Transplant"},{"issue":"6937","key":"3992_CR41","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1038\/nature01657","volume":"423","author":"HM Kronenberg","year":"2003","unstructured":"Kronenberg HM. Developmental regulation of the growth plate. Nature. 2003;423(6937):332\u20136. https:\/\/doi.org\/10.1038\/nature01657.","journal-title":"Nature"},{"issue":"11","key":"3992_CR42","doi-asserted-by":"publisher","first-page":"2800","DOI":"10.3390\/ijms20112800","volume":"20","author":"CM Zheng","year":"2019","unstructured":"Zheng CM, Hsu YH, Wu CC, Lu CL, Liu WC, Zheng JQ, Lin YF, Chiu HW, Chang TJ, Shyu JF, Lu KC. Osteoclast-released Wnt-10b underlies cinacalcet related bone improvement in chronic kidney disease. Int J Mol Sci. 2019;20(11):2800. https:\/\/doi.org\/10.3390\/ijms20112800.","journal-title":"Int J Mol Sci"},{"issue":"22","key":"3992_CR43","doi-asserted-by":"publisher","first-page":"8712","DOI":"10.3390\/ijms21228712","volume":"21","author":"KC Hung","year":"2020","unstructured":"Hung KC, Chang JF, Hsu YH, Hsieh CY, Wu MS, Wu MY, Chiu IJ, Syu RS, Wang TM, Wu CC, Hung LY, Zheng CM, Lu KC. Therapeutic effect of calcimimetics on osteoclast-osteoblast crosslink in chronic kidney disease and mineral bone disease. Int J Mol Sci. 2020;21(22):8712. https:\/\/doi.org\/10.3390\/ijms21228712.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"3992_CR44","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.kint.2016.01.024","volume":"90","author":"N Carrillo-L\u00f3pez","year":"2016","unstructured":"Carrillo-L\u00f3pez N, Panizo S, Alonso-Montes C, Rom\u00e1n-Garc\u00eda P, Rodr\u00edguez I, Mart\u00ednez-Salgado C, et al. Direct inhibition of osteoblastic Wnt pathway by fibroblast growth factor 23 contributes to bone loss in chronic kidney disease. Kidney Int. 2016;90(1):77\u201389. https:\/\/doi.org\/10.1016\/j.kint.2016.01.024.","journal-title":"Kidney Int"},{"issue":"4","key":"3992_CR45","doi-asserted-by":"publisher","first-page":"F882","DOI":"10.1152\/ajprenal.00360.2010","volume":"299","author":"V Lavi-Moshayoff","year":"2010","unstructured":"Lavi-Moshayoff V, Wasserman G, Meir T, Silver J, Naveh-Many T. PTH increases FGF23 gene expression and mediates the high-FGF23 levels of experimental kidney failure: a bone parathyroid feedback loop. Am J Physiol Renal Physiol. 2010;299(4):F882-9. https:\/\/doi.org\/10.1152\/ajprenal.00360.2010.","journal-title":"Am J Physiol Renal Physiol"},{"issue":"4","key":"3992_CR46","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s00223-020-00803-2","volume":"108","author":"N Carrillo-L\u00f3pez","year":"2021","unstructured":"Carrillo-L\u00f3pez N, Mart\u00ednez-Arias L, Fern\u00e1ndez-Villabrille S, Ruiz-Torres MP, Dusso A, Cannata-And\u00eda JB, et al. Role of the RANK\/RANKL\/OPG and Wnt\/\u03b2-catenin systems in CKD bone and cardiovascular disorders. Calcif Tissue Int. 2021;108(4):439\u201351. https:\/\/doi.org\/10.1007\/s00223-020-00803-2.","journal-title":"Calcif Tissue Int"},{"issue":"6","key":"3992_CR47","doi-asserted-by":"publisher","first-page":"432","DOI":"10.5414\/cnp62432","volume":"62","author":"R Lob\u00e3o","year":"2004","unstructured":"Lob\u00e3o R, Carvalho AB, Cuppari L, Ventura R, Lazaretti-Castro M, Jorgetti V, et al. High prevalence of low bone mineral density in pre-dialysis chronic kidney disease patients: bone histomorphometric analysis. Clin Nephrol. 2004;62(6):432\u20139. https:\/\/doi.org\/10.5414\/cnp62432.","journal-title":"Clin Nephrol"},{"issue":"7","key":"3992_CR48","doi-asserted-by":"publisher","first-page":"e0133278","DOI":"10.1371\/journal.pone.0133278","volume":"10","author":"HW Liao","year":"2015","unstructured":"Liao HW, Hung PH, Hsiao CY, Liou HH, Lin HS, Huang TH, et al. Relationship between fibroblast growth factor 23 and biochemical and bone histomorphometric alterations in a chronic kidney disease rat model undergoing parathyroidectomy. PLoS ONE. 2015;10(7):e0133278. https:\/\/doi.org\/10.1371\/journal.pone.0133278.","journal-title":"PLoS ONE"},{"issue":"15","key":"3992_CR49","doi-asserted-by":"publisher","first-page":"8352","DOI":"10.1073\/pnas.140021997","volume":"97","author":"GR Beck Jr","year":"2000","unstructured":"Beck GR Jr, Zerler B, Moran E. Phosphate is a specific signal for induction of osteopontin gene expression. Proc Natl Acad Sci U S A. 2000;97(15):8352\u20137. https:\/\/doi.org\/10.1073\/pnas.140021997.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"3992_CR50","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/s8756-3282(00)00346-x","volume":"27","author":"Z Meleti","year":"2000","unstructured":"Meleti Z, Shapiro IM, Adams CS. Inorganic phosphate induces apoptosis of osteoblast-like cells in culture. Bone. 2000;27(3):359\u201366. https:\/\/doi.org\/10.1016\/s8756-3282(00)00346-x.","journal-title":"Bone"},{"issue":"1","key":"3992_CR51","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1002\/jcp.10270","volume":"196","author":"M Kanatani","year":"2003","unstructured":"Kanatani M, Sugimoto T, Kano J, Kanzawa M, Chihara K. Effect of high phosphate concentration on osteoclast differentiation as well as bone-resorbing activity. J Cell Physiol. 2003;196(1):180\u20139. https:\/\/doi.org\/10.1002\/jcp.10270.","journal-title":"J Cell Physiol"},{"issue":"3","key":"3992_CR52","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1210\/er.2017-00220","volume":"39","author":"Y Kinoshita","year":"2018","unstructured":"Kinoshita Y, Fukumoto S. X-linked hypophosphatemia and FGF23-related hypophosphatemic diseases: prospect for new treatment. Endocr Rev. 2018;39(3):274\u201391. https:\/\/doi.org\/10.1210\/er.2017-00220.","journal-title":"Endocr Rev"},{"issue":"5","key":"3992_CR53","doi-asserted-by":"publisher","first-page":"e0252348","DOI":"10.1371\/journal.pone.0252348","volume":"16","author":"Y Yuan","year":"2021","unstructured":"Yuan Y, Jagga S, Martins JS, Rana R, Pajevic PD, Liu ES. Impaired 1,25 dihydroxyvitamin D3 action and hypophosphatemia underlie the altered lacuno-canalicular remodeling observed in the Hyp mouse model of XLH. PLoS ONE. 2021;16(5):e0252348. https:\/\/doi.org\/10.1371\/journal.pone.0252348.","journal-title":"PLoS ONE"},{"issue":"27","key":"3992_CR54","doi-asserted-by":"publisher","first-page":"9637","DOI":"10.1073\/pnas.0502249102","volume":"102","author":"Y Sabbagh","year":"2005","unstructured":"Sabbagh Y, Carpenter TO, Demay MB. Hypophosphatemia leads to rickets by impairing caspase-mediated apoptosis of hypertrophic chondrocytes. Proc Natl Acad Sci U S A. 2005;102(27):9637\u201342. https:\/\/doi.org\/10.1073\/pnas.0502249102.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"3992_CR55","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1111\/nep.14022","volume":"27","author":"S Udomkarnjananun","year":"2022","unstructured":"Udomkarnjananun S, Phannajit J, Takkavatakarn K, Tumkosit M, Kingpetch K, Avihingsanon Y, et al. Effects of phosphate binders on bone biomarkers and bone density in haemodialysis patients. Nephrology (Carlton). 2022;27(5):441\u20139. https:\/\/doi.org\/10.1111\/nep.14022.","journal-title":"Nephrology (Carlton)"},{"issue":"6","key":"3992_CR56","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1007\/s00774-019-01018-8","volume":"37","author":"K Goto","year":"2019","unstructured":"Goto K, Goto S, Fujii H, Watanabe K, Kono K, Nishi S. Effects of lanthanum carbonate on bone markers and bone mineral density in incident hemodialysis patients. J Bone Miner Metab. 2019;37(6):1075\u201382. https:\/\/doi.org\/10.1007\/s00774-019-01018-8.","journal-title":"J Bone Miner Metab"},{"issue":"1","key":"3992_CR57","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s00198-017-4228-4","volume":"29","author":"HH Malluche","year":"2018","unstructured":"Malluche HH, Monier-Faugere MC, Blomquist G, Davenport DL. Two-year cortical and trabecular bone loss in CKD-5D: biochemical and clinical predictors. Osteoporos Int. 2018;29(1):125\u201334. https:\/\/doi.org\/10.1007\/s00198-017-4228-4. Epub 2017 Oct 9 PMID: 28993865.","journal-title":"Osteoporos Int"},{"issue":"2","key":"3992_CR58","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1681\/ASN.2006101089","volume":"19","author":"A Ferreira","year":"2008","unstructured":"Ferreira A, Fraz\u00e3o JM, Monier-Faugere MC, Gil C, Galvao J, Oliveira C, et al. Effects of sevelamer hydrochloride and calcium carbonate on renal osteodystrophy in hemodialysis patients. J Am Soc Nephrol. 2008;19(2):405\u201312. https:\/\/doi.org\/10.1681\/ASN.2006101089.","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"3992_CR59","doi-asserted-by":"publisher","first-page":"269","DOI":"10.5414\/cnp69269","volume":"69","author":"HH Malluche","year":"2008","unstructured":"Malluche HH, Monier-Faugere MC, Wang G, Fraz\u00e3 OJM, Charytan C, Coburn JW, et al. An assessment of cinacalcet HCl effects on bone histology in dialysis patients with secondary hyperparathyroidism. Clin Nephrol. 2008;69(4):269\u201378. https:\/\/doi.org\/10.5414\/cnp69269.","journal-title":"Clin Nephrol"},{"key":"3992_CR60","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1159\/000403277","volume":"18","author":"HH Malluche","year":"1980","unstructured":"Malluche HH, Goldstein DA, Massry SG. Effects of 6 months therapy with 1,25 (OH)2D3 on bone disease of dialysis patients. Contrib Nephrol. 1980;18:98\u2013104. https:\/\/doi.org\/10.1159\/000403277.","journal-title":"Contrib Nephrol"},{"issue":"4","key":"3992_CR61","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/j.bone.2007.06.026","volume":"41","author":"M Naves D\u00edaz","year":"2007","unstructured":"Naves D\u00edaz M, Rodr\u00edguez Rodr\u00edguez A, Fern\u00e1ndez Mart\u00edn JL, Serrano Arias M, Men\u00e9ndez Rodr\u00edguez P, Cannata And\u00eda JB. Effects of estradiol, calcitriol and both treatments combined on bone histomorphometry in rats with chronic kidney disease and ovariectomy. Bone. 2007;41(4):614\u20139. https:\/\/doi.org\/10.1016\/j.bone.2007.06.026.","journal-title":"Bone"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-03992-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-025-03992-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-03992-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T23:35:18Z","timestamp":1739316918000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-025-03992-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,11]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3992"],"URL":"https:\/\/doi.org\/10.1186\/s12882-025-03992-w","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,11]]},"assertion":[{"value":"21 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"68"}}